Lista de obras -

A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection

artículo científico publicado en 2002

Adult-onset Still's disease--case report

artículo científico publicado en 2007

Antiviral treatment of chronic B hepatitis; 2010 - therapeutic recommendations

artículo científico publicado en 2010

Atypical course of chicken-pox complicated by hepatitis and endocarditis

artículo científico publicado en 2004

Bacterial endocarditis in the course of sepsis in 7th month of treatment with peginterferon alfa and ribavirin in patient with chronic hepatitis C

artículo científico publicado en 2007

C-reactive protein and chronic hepatitis C virus infection in diabetic patients

artículo científico publicado en 2010

Cefepime: the new option of target antibiotic therapy

artículo científico publicado el 1 de enero de 2003

Diagnostic difficulties in febrile travellers returning from the tropics. Two cases of typhoid fever imported from India

artículo científico publicado en 2002

Effectiveness of antiviral treatment of patients with chronic hepatitis C (a Polish multicenter study)

artículo científico publicado el 1 de octubre de 2001

Global strategies in prevention of infectious diseases on the turn of the second and third millennium: expectation versus reality

artículo científico publicado en 2004

Hepatitis C virus infection: evidence for an association with type 2 diabetes

artículo científico publicado en 2006

Incidence of haemolytic anaemia during combination therapy of chronic hepatitis C with interferon alpha-2b and ribavirin

artículo científico publicado en 2004

Interferon alpha, gamma, omega before and during treatment of chronic hepatitis C with pegylated interferon alpha and ribavirin

artículo científico publicado en 2007

Interleukin-2 (IL-2) expression in livers of patients with chronic hepatitis C virus (HCV) infection.

artículo científico publicado en 2006

Intracellular expression of the proliferative marker Ki-67 and viral proteins (NS3, NS5A and C) in chronic, long lasting hepatitis C virus (HCV) infection

artículo científico publicado en 2007

Long-term viral response to interferon alpha 2b plus ribavirin in chronic hepatitis C patients during standard therapy

artículo científico publicado en 2007

Mutations within protein kinase R-binding domain of NS5A protein of hepatitis C virus (HCV) and specificity of HCV antibodies in pretreatment sera of HCV-chronically infected patients and their effect on the result of treatment.

artículo científico publicado en 2006

Optimization of the method of treatment of chronic viral hepatitis C with pegylated interferon-alfa and ribavirin

artículo científico publicado en 2006

Peginterferon alpha-2b in patients with chronic hepatitis C

artículo científico publicado en 2004

Pegylated interferon-alfa 2a with ribavirin in chronic viral hepatitis C (final report)

artículo científico publicado en 2005

Place of consensus type interferon alpha in the management of chronic type C hepatitis

artículo científico publicado en 2003

Polish Group of Experts of HBV--collective to vaccinations: vaccinations against hepatitis A and B

artículo científico publicado el 1 de enero de 2012

Polish multicenter study on safety and efficacy of adefovir dipivoxil in the treatment of lamivudine resistant chronic hepatitis B in adults (HEP 2008)

artículo científico publicado el 1 de enero de 2011

Prevalence and risk factors of HCV infection in Poland

artículo científico publicado en 2011

Recommendations for the treatment of hepatitis B in 2017

artículo científico publicado en 2017

Recommendations for the treatment of hepatitis C Polish group of HCV Experts--2015

artículo científico publicado en 2015

Recommendations for the treatment of hepatitis C in 2017

artículo científico publicado en 2017

Recommendations for the treatment of hepatitis C issued by the Polish Group of HCV Experts - 2016

artículo científico publicado en 2016

Recommendations for treatment of hepatitis C. Polish Group of HCV Experts - 2015

scientific article published on 16 November 2015

Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2020

artículo científico publicado en 2020

Serum iron parameters in chronic hepatitis C patients and comparison of the results before and during antiviral treatment

artículo científico publicado en 2005

Serum metabolite/caffeine ratios as a test for liver function

artículo científico publicado en 2004

Spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis based on bacteriological and biochemical results

artículo científico publicado en 2004

Standards of hepatitis C treatment. Recommendations of Polish Group of Experts--2014

artículo científico publicado en 2014

Standards of treatment of the hepatitis C (June 2008)

artículo científico publicado en 2009

Therapeutic recommendations for 2013: antiviral treatment for chronic hepatitis B.

artículo científico publicado en 2013

Therapeutic recommendations for year 2010: antiviral treatment of chronic HBV infection

artículo científico publicado en 2010

[Fifteen years of investigations on hepatitis C virus in Poland]

artículo científico publicado en 2005

[Infections: an inseparable part of medicine]

scientific article published on 01 January 2003

[Monotherapy or synergic treatment for sepsis caused by Pseudomonas aeruginosa]

scientific article published on 01 January 2003

[Polish Experts Group on HBV. Therapeutic recommendations on 2008 year (antiretroviral treatment of chronic hepatitis B)]

artículo científico publicado en 2008

[Procalcitonin as a diagnostic marker in systemic inflammatory response syndrome (SIRS) and sepsis]

artículo científico publicado en 2006

[Standards of hepatitis C treatment. Recommendations of Polish Group of Experts]

artículo científico publicado en 2012

[Viral hepatitis type C: new facts and hypotheses]

artículo científico publicado en 2002

p53 immunocytochemistry and TP53 gene mutations in patients with chronic hepatitis C virus (HCV) infection.

artículo científico publicado en 2009

Lista de obras de

A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection

Adult-onset Still's disease--case report

Antiviral treatment of chronic B hepatitis; 2010 - therapeutic recommendations

Atypical course of chicken-pox complicated by hepatitis and endocarditis

Bacterial endocarditis in the course of sepsis in 7th month of treatment with peginterferon alfa and ribavirin in patient with chronic hepatitis C

C-reactive protein and chronic hepatitis C virus infection in diabetic patients

Cefepime: the new option of target antibiotic therapy

Diagnostic difficulties in febrile travellers returning from the tropics. Two cases of typhoid fever imported from India

Effectiveness of antiviral treatment of patients with chronic hepatitis C (a Polish multicenter study)

Global strategies in prevention of infectious diseases on the turn of the second and third millennium: expectation versus reality

Hepatitis C virus infection: evidence for an association with type 2 diabetes

Incidence of haemolytic anaemia during combination therapy of chronic hepatitis C with interferon alpha-2b and ribavirin

Interferon alpha, gamma, omega before and during treatment of chronic hepatitis C with pegylated interferon alpha and ribavirin

Interleukin-2 (IL-2) expression in livers of patients with chronic hepatitis C virus (HCV) infection.

Intracellular expression of the proliferative marker Ki-67 and viral proteins (NS3, NS5A and C) in chronic, long lasting hepatitis C virus (HCV) infection

Long-term viral response to interferon alpha 2b plus ribavirin in chronic hepatitis C patients during standard therapy

Mutations within protein kinase R-binding domain of NS5A protein of hepatitis C virus (HCV) and specificity of HCV antibodies in pretreatment sera of HCV-chronically infected patients and their effect on the result of treatment.

Optimization of the method of treatment of chronic viral hepatitis C with pegylated interferon-alfa and ribavirin

Peginterferon alpha-2b in patients with chronic hepatitis C

Pegylated interferon-alfa 2a with ribavirin in chronic viral hepatitis C (final report)

Place of consensus type interferon alpha in the management of chronic type C hepatitis

Polish Group of Experts of HBV--collective to vaccinations: vaccinations against hepatitis A and B

Polish multicenter study on safety and efficacy of adefovir dipivoxil in the treatment of lamivudine resistant chronic hepatitis B in adults (HEP 2008)

Prevalence and risk factors of HCV infection in Poland

Recommendations for the treatment of hepatitis B in 2017

Recommendations for the treatment of hepatitis C Polish group of HCV Experts--2015

Recommendations for the treatment of hepatitis C in 2017

Recommendations for the treatment of hepatitis C issued by the Polish Group of HCV Experts - 2016

Recommendations for treatment of hepatitis C. Polish Group of HCV Experts - 2015

Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2020

Serum iron parameters in chronic hepatitis C patients and comparison of the results before and during antiviral treatment

Serum metabolite/caffeine ratios as a test for liver function

Spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis based on bacteriological and biochemical results

Standards of hepatitis C treatment. Recommendations of Polish Group of Experts--2014

Standards of treatment of the hepatitis C (June 2008)

Therapeutic recommendations for 2013: antiviral treatment for chronic hepatitis B.

Therapeutic recommendations for year 2010: antiviral treatment of chronic HBV infection

[Fifteen years of investigations on hepatitis C virus in Poland]

[Infections: an inseparable part of medicine]

[Monotherapy or synergic treatment for sepsis caused by Pseudomonas aeruginosa]

[Polish Experts Group on HBV. Therapeutic recommendations on 2008 year (antiretroviral treatment of chronic hepatitis B)]

[Procalcitonin as a diagnostic marker in systemic inflammatory response syndrome (SIRS) and sepsis]

[Standards of hepatitis C treatment. Recommendations of Polish Group of Experts]

[Viral hepatitis type C: new facts and hypotheses]

p53 immunocytochemistry and TP53 gene mutations in patients with chronic hepatitis C virus (HCV) infection.